Abstract:Abstract Background Guidelines recommend cardiovascular risk reduction and supervised exercise therapy as the first line of treatment in intermittent claudication, but implementation challenges and poor patient compliance lead to significant variation in management and therefore outcomes. The development of a precise risk stratification tool is proposed through a machine-learning algorithm that aims to provide personalized outcome predictions for different management strategies. Methods Feature selection was performed using the least absolute shrinkage and selection operator method. The model was developed using a bootstrapped sample based on patients with intermittent claudication from a vascular centre to predict chronic limb-threatening ischaemia, two or more revascularization procedures, major adverse cardiovascular events, and major adverse limb events. Algorithm performance was evaluated using the area under the receiver operating characteristic curve. Calibration curves were generated to assess the consistency between predicted and actual outcomes. Decision curve analysis was employed to evaluate the clinical utility. Validation was performed using a similar dataset. Results The bootstrapped sample of 10 000 patients was based on 255 patients. The model was validated using a similar sample of 254 patients. The area under the receiver operating characteristic curves for risk of progression to chronic limb-threatening ischaemia at 2 years (0.892), risk of progression to chronic limb-threatening ischaemia at 5 years (0.866), likelihood of major adverse cardiovascular events within 5 years (0.836), likelihood of major adverse limb events within 5 years (0.891), and likelihood of two or more revascularization procedures within 5 years (0.896) demonstrated excellent discrimination. Calibration curves demonstrated good consistency between predicted and actual outcomes and decision curve analysis confirmed clinical utility. Logistic regression yielded slightly lower area under the receiver operating characteristic curves for these outcomes compared with the least absolute shrinkage and selection operator algorithm (0.728, 0.717, 0.746, 0.756, and 0.733 respectively). External calibration curve and decision curve analysis confirmed the reliability and clinical utility of the model, surpassing traditional logistic regression. Conclusion The machine-learning algorithm successfully predicts outcomes for patients with intermittent claudication across various initial treatment strategies, offering potential for improved risk stratification and patient outcomes.

Regression trees for interval‐censored failure time data based on censoring unbiased transformations and pseudo‐observations

From regression rank scores to robust inference for censored quantile regression

Estimation of the additive hazards model based on case‐cohort interval‐censored data with dependent censoring

Semiparametric predictive inference for failure data using first-hitting-time threshold regression

Regression analysis of multivariate current status data under a varying coefficients additive hazards frailty model

Survival Trees for Interval-Censored Survival data

A conditional approach for regression analysis of case K interval-censored failure time data with informative censoring

A new and unified method for regression analysis of interval‐censored failure time data under semiparametric transformation models with missing covariates

Censored autoregressive regression models with Student‐t innovations

Semiparametric regression analysis of failure time data with dependent interval censoring

Regression Trees for Fast and Adaptive Prediction Intervals

Regression analysis of bivariate current status data under the proportional hazards model

Regression Analysis of Right-Censored Failure Time Data with Missing Censoring Indicators

Dynamic Risk Prediction Triggered by Intermediate Events Using Survival Tree Ensembles

Estimating optimal tailored active surveillance strategy under interval censoring

Generalized Bayesian Additive Regression Trees for Restricted Mean Survival Time Inference

Robust Evaluation of Longitudinal Surrogate Markers with Censored Data

Tree based weighted learning for estimating individualized treatment rules with censored data

Evaluating Prognostic Biomarkers for Survival Outcomes Subject to Informative Censoring.

Tailored risk assessment and forecasting in intermittent claudication